Skip to content
Home/ Gaucher Disease
Gaucher Disease

Gaucher Disease

No customer reviews yet ISBN 9780367390617 CRC Press

The most current and comprehensive reference available, Gaucher Disease provides valuable information for academic and industry scientists, and clinicians. Outlining current research on the biochemistry and pathology of lysosomal storage disorders, this book covers diverse topics including animal models, crystallography, imaging and radionuclide evaluation. It addresses treatments such as enzyme replacement therapy, as well as emerging therapies. With contributions from world-renowned experts this book includes discussions on patient management, the ethics of research, and the use of expensive therapies to treating orphan diseases. In September of 2007, Gaucher Disease received a commendation in the Haematology category of the 2007 British Medical Association Medical Book Competition.

About the author

Product details

BrandCRC Press
Pub dateOct 17, 2019
ISBN-100367390612
ISBN-139780367390617
LanguageEnglish
Dimensions9 × 1 × 6 in
Weight2 lb
Last updated 2026-03-12 08:25
$99.05
In stock — ships in 24 hours with free tracking
Delivery by Monday, September 14, 2026
Qty
Sign in to Add to Saved list
Free delivery on orders over $35.
15-day returns. Any reason.
Secure checkout. We never store card details.

Readers who bought this also bought

More from Genetics
See all
Polymers and Nanomaterials for Gene Therapy
<p><i>Polymers and Nanomaterials for Gene Therapy</i> provides the latest information on gene therapy, a topic that has attracted significant attention over the past two decades for the treatment of inherited and acquired genetic diseases. Major research efforts are currently focused on designing suitable carrier vectors that compact and protect oligonucleotides for gene therapy.</p> <p>The book explores the most recent developments in the field of polymer science and nanotechnology, and how these advancements have helped in the design of advanced materials. Non-viral vector systems, including cationic lipids, polymers, dendrimers, peptides and nanoparticles, are potential routes for compacting DNA for systemic delivery. However, unlike viral analogues that have no difficulty in overcoming cellular barriers and immune defense mechanisms, non-viral gene carriers consistently exhibit significant reduced transfection efficiency due to numerous extra- and intracellular obstacles. Therefore, biocompatibility and potential for large-scale production make these compounds increasingly attractive for gene therapy.</p> <p>This book contains chapters on the engineering of polymers and nanomaterials for gene therapy, and how they can form complexes with DNA and avoid both in vitro and in vivo barriers. Other chapters describe in vitro, ex vivo, in vivo gene therapy studies, and the current issues affecting non-viral gene therapy.</p>
$242.85